Please do not leave this page until complete. This can take a few moments.
While San Jose, Calif.-based Cisco may be known for its computer hardware products, it is less well-known for its investment strategy in local companies.
Oxford-based laser maker IPG Photonics Corp. has issued common stock worth about $729,000 in order to purchase a minority interest in a Japanese subsidiary, the company said in a U.S.
RXi Pharmaceuticals Inc. of Worcester increased its first-quarter loss 57 percent this year as it ramped up hiring, patent applications and other expenses.
After 22 years in business, American Superconductor turned a profit for the first time in the fourth quarter of its 2008 fiscal year.
Marlborough-based Sepracor has officially ended plans to bring its sleep aid Lunesta to Europe.
Seagate Technology, a California-based hard disk drive company with operations in Shrewsbury, will lay off 2.5 percent of the company's global workforce, or 1,100 employees.
Boston Scientific Corp. of Natick says new real-world data shows better survival rates for patients using its implantable cardiac devices than clinical trials suggested.
Drug sales for the world's top 10 pharmaceutical companies slowed significantly in 2008, according to Waltham-based Decision Resources.
A Worcester Polytechnic Institute computer science student has been awarded $1,000 and is a national finalist for a Google Anita Borg Memorial Scholarship.
Capaccio Environmental Engineering Inc., a Marlborough environmental, health and safety consulting company, has hired Geoffrey J. Gilbert and Jill Seifert Vernes.
Worcester-based Advanced Cell Technology Inc. reported net losses of $5.6 million and $12.6 million for the second and third quarters of 2008, respectively.
People are used to hearing about research with the potential to cure or mitigate some of life’s many diseases.
Psychemedics Corp. of Acton said it ended the first quarter with a $39,000 profit on $4.1 million in revenue, both significant declines from a year ago.
Fitchburg-based Arrhythmia Research Technology Inc. and its wholly owned subsidiary Micron Products Inc. said "continuing price erosion" was in part responsible for its weak first quarter performance.
Framingham-based GTC Biotherapeutics Inc. said its anti-clotting drug ATryn is now commercially available in the United States.